Philips introduces first-of-a-kind mobile ICUs in India to tackle COVID-19 and other emergencies
July 07 2020 - 4:00AM
Amsterdam, the Netherlands and New Delhi, India
– Royal Philips (NYSE: PHG, AEX: PHIA), a global
leader in health technology, today announced it introduced
first-of-its-kind mobile Intensive Care Units (ICUs) in India.
Designed to meet the critical-care requirements of patients, each
prefabricated ICU has a capacity of nine beds. The units will be
locally manufactured by Philips in India, with each ICU unit
capable of being deployed in one day.
India is in the top 5 countries with the highest amount of
COVID-19 cases. The country’s healthcare system is under immense
pressure as infections spike. Leveraging its clinical, technical
and design expertise, Philips has developed new mobile ICUs to
address the challenging needs of critical-care services in India.
They will be useful to government agencies and health systems
looking to rapidly increase ICU capacity and enhance community
outreach with the aim to mitigate the impact of natural disasters
and pandemics such as the ongoing COVID-19 outbreak.
With a floor area of 1380 square feet (128 square meters), these
self-sufficient units only require an on-site electricity and water
connection to become operational. Each mobile ICU comes
pre-equipped with a state-of-the-art critical-care infrastructure,
such as independent patient cubicles, plus anti-bacterial paint and
high-end washrooms with a self-disinfection facility to avoid cross
contamination. The ICUs can be furnished with a range of medical
equipment, including ventilators, defibrillators, a central
monitoring station and CPAP (Continuous Positive Airway Pressure)
machines, with appropriate supporting infrastructure such as
back-up power, oxygen and vacuum supplies.
“Aligned with the government’s commitment to providing quality
and accessible healthcare to India’s population, we are proud to
introduce our state-of-the-art mobile ICUs for India,” said Daniel
Mazon, General Manager Philips India. “We believe this solution
will help the country to tackle COVID-19 in an effective manner as
it enables healthcare institutions to increase their critical-care
bed capacities. The solution will also be significant in the long
term to address future critical care requirements.”
“Philips’ mobile ICU solution will offer great advantage in
treatment of isolated patients, in disaster management, and for
community outreach,” said Mahipal Singh Bhanot, Zonal Director of
Fortis Healthcare. “Additionally, it will enable streamlining of
hospital workflows without the need to change their protocols for
infectious patients, while maintaining patient and staff safety.
This can be a productive asset to have, especially because it is
useful in adding additional beds to hospitals in a much reduced
time, which means rapid ramp up of a hospital’s bed capacity.”
Tele-critical care command centersNext to the
mobile ICUs Philips is also offering a dedicated tele-critical care
command center solution for the Indian market helping hospitals to
improve access to acute care and leverage scarce resources such as
trained ICU staff in optimized ways. These highly trained
intensivists and intensive care nurses are stationed in a central
hub and can connect to and remotely monitor patients in peripheral
ICUs on a 24/7 basis through advanced dashboards that bring
together vital signs, lab values and predictive analytics.
Currently there are 5 major tele-critical care command centers in
India and these hubs are connected to up to 700 ICU beds across
country with Tier 2, 3 city hospitals.
Philips COVID-19 solutions portfolioPhilips has
a comprehensive portfolio of services and solutions which can help
to support the delivery of high-quality care to COVID-19 patients.
It includes secure, connected and intelligent approaches to
diagnosis, treatment and predictive monitoring in the hospital,
plus screening, remote patient monitoring and care at home. With
healthcare under more pressure than ever before, Philips’
telehealth and AI-enabled data analytics can help support
workflows, facilitate remote collaboration and optimize resources.
Philips’ COVID-19-related solutions are designed for rapid
deployment and scalability. For more information on how Philips is
addressing COVID-19 globally, please visit the Philips centralized
COVID-19 hub.
For further information, please
contact: Joost MalthaPhilips Global Press
OfficeTel.: +31 6 10 55 8116E-mail: joost.maltha@philips.com
Geetika BangiaPhilips IndiaTel.: +91 981 810 2133E-mail:
geetika.bangia@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
enabling better outcomes across the health continuum from healthy
living and prevention, to diagnosis, treatment and home care.
Philips leverages advanced technology and deep clinical and
consumer insights to deliver integrated solutions. Headquartered in
the Netherlands, the company is a leader in diagnostic imaging,
image-guided therapy, patient monitoring and health informatics, as
well as in consumer health and home care. Philips generated 2019
sales of EUR 19.5 billion and employs approximately 81,000
employees with sales and services in more than 100 countries. News
about Philips can be found at www.philips.com/newscenter.
Koninklijke Philips NV (NYSE:PHG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Koninklijke Philips NV (NYSE:PHG)
Historical Stock Chart
From Apr 2023 to Apr 2024